| |
| |
| |
| |
| |
| | | | |
|
PR:P42771-1 | cyclin-dependent kinase inhibitor 2A isoform h1 (human) | | | | | |
| | | | |
|
PR:P42771-2 | cyclin-dependent kinase inhibitor 2A isoform h2 (human) | | | | | |
| | | | |
|
PR:P42771-3 | cyclin-dependent kinase inhibitor 2A isoform h3 (human) | | | | | |
| | | | |
|
PR:P42771-4 | cyclin-dependent kinase inhibitor 2A isoform h5 (human) | | | | | |
| | | | |
|
PR:P42771 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 (human) | | | | | |
| | | | | |
|
PR:P42771-1 | cyclin-dependent kinase inhibitor 2A isoform h1 (human) | | | | | |
| | | | | |
|
PR:P42771-2 | cyclin-dependent kinase inhibitor 2A isoform h2 (human) | | | | | |
| | | | | |
|
PR:P42771-3 | cyclin-dependent kinase inhibitor 2A isoform h3 (human) | | | | | |
| | | | | |
|
PR:P42771-4 | cyclin-dependent kinase inhibitor 2A isoform h5 (human) | | | | | |
| | | | | |
|
PR:000064035 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A20E (human) | | | | | |
| | | | | |
|
PR:000061447 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A20P (human) | | | | | |
| | | | | |
|
PR:000062210 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A20T (human) | | | | | |
| | | | | |
|
PR:000061910 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A60E (human) | | | | | |
| | | | | |
|
PR:000060772 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A60R (human) | | | | | |
| | | | | |
|
PR:000064504 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A60S (human) | | | | | |
| | | | | |
|
PR:000063093 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant A60V (human) | | | | | |
| | | | | |
|
PR:000060674 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant C72* (human) | | | | | |
| | | | | |
|
PR:000062221 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D74Y (human) | | | | | |
| | | | | |
|
PR:000060662 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D84A (human) | | | | | |
| | | | | |
|
PR:000060619 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D84G (human) | | | | | |
| | | | | |
|
PR:000060872 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D84H (human) | | | | | |
| | | | | |
|
PR:000061499 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D84N (human) | | | | | |
| | | | | |
|
PR:000061835 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D84V (human) | | | | | |
| | | | | |
|
PR:000061773 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant D84Y (human) | | | | | |
| | | | | |
|
PR:000062784 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E10* (human) | | | | | |
| | | | | |
|
PR:000060756 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E119* (human) | | | | | |
| | | | | |
|
PR:000062258 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E120* (human) | | | | | |
| | | | | |
|
PR:000060508 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E26* (human) | | | | | |
| | | | | |
|
PR:000061873 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E27* (human) | | | | | |
| | | | | |
|
PR:000062914 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E33* (human) | | | | | |
| | | | | |
|
PR:000061985 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E61* (human) | | | | | |
| | | | | |
|
PR:000060431 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E69* (human) | | | | | |
| | | | | |
|
PR:000060989 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E88* (human) | | | | | |
| | | | | |
|
PR:000060291 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant E88K (human) | | | | | |
| | | | | |
|
PR:000063287 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G101V (human) | | | | | |
| | | | | |
|
PR:000062706 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G101W (human) | | | | | |
| | | | | |
|
PR:000063600 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G23D (human) | | | | | |
| | | | | |
|
PR:000062667 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G23S (human) | | | | | |
| | | | | |
|
PR:000063351 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G23V (human) | | | | | |
| | | | | |
|
PR:000064411 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G35A (human) | | | | | |
| | | | | |
|
PR:000061664 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G35E (human) | | | | | |
| | | | | |
|
PR:000063607 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G35R (human) | | | | | |
| | | | | |
|
PR:000062895 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G35V (human) | | | | | |
| | | | | |
|
PR:000060604 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant G35W (human) | | | | | |
| | | | | |
|
PR:000063995 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant L97P (human) | | | | | |
| | | | | |
|
PR:000064574 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant L97R (human) | | | | | |
| | | | | |
|
PR:000061452 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant M53I (human) | | | | | |
| | | | | |
|
PR:000061363 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P114H (human) | | | | | |
| | | | | |
|
PR:000063064 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P114L (human) | | | | | |
| | | | | |
|
PR:000063651 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P114R (human) | | | | | |
| | | | | |
|
PR:000062768 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P114S (human) | | | | | |
| | | | | |
|
PR:000060532 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P114T (human) | | | | | |
| | | | | |
|
PR:000064284 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P75* (human) | | | | | |
| | | | | |
|
PR:000062363 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P81H (human) | | | | | |
| | | | | |
|
PR:000064115 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P81L (human) | | | | | |
| | | | | |
|
PR:000060486 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P81R (human) | | | | | |
| | | | | |
|
PR:000062515 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P81S (human) | | | | | |
| | | | | |
|
PR:000063957 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant P81T (human) | | | | | |
| | | | | |
|
PR:000061791 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant Q50* (human) | | | | | |
| | | | | |
|
PR:000062735 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant R24P (human) | | | | | |
| | | | | |
|
PR:000062454 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant R58* (human) | | | | | |
| | | | | |
|
PR:000062157 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant R80* (human) | | | | | |
| | | | | |
|
PR:000062060 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant R80P (human) | | | | | |
| | | | | |
|
PR:000062732 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant R87P (human) | | | | | |
| | | | | |
|
PR:000061471 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant R99P (human) | | | | | |
| | | | | |
|
PR:000060412 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant S12* (human) | | | | | |
| | | | | |
|
PR:000064017 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant T77P (human) | | | | | |
| | | | | |
|
PR:000061194 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant T77S (human) | | | | | |
| | | | | |
|
PR:000062437 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant V126A (human) | | | | | |
| | | | | |
|
PR:000062962 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant V126D (human) | | | | | |
| | | | | |
|
PR:000061521 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant V126F (human) | | | | | |
| | | | | |
|
PR:000062812 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant V126I (human) | | | | | |
| | | | | |
|
PR:000060679 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant W110* (human) | | | | | |
| | | | | |
|
PR:000062318 | cyclin-dependent kinase inhibitor 2A, isoforms h1/h2/h3/h5 sequence variant W15* (human) | | | | | |
| |
| |
| |
| |
| |
| |
| | | | |
|
PR:P51480-1 | cyclin-dependent kinase inhibitor 2A isoform m1 (mouse) | | | | | |
| | | | |
|
PR:P51480-2 | cyclin-dependent kinase inhibitor 2A isoform m2 (mouse) | | | | | |
| | | | |
|
PR:P51480 | cyclin-dependent kinase inhibitor 2A isoforms m1/m2 (mouse) | | | | | |
| | | | | |
|
PR:P51480-1 | cyclin-dependent kinase inhibitor 2A isoform m1 (mouse) | | | | | |
| | | | | |
|
PR:P51480-2 | cyclin-dependent kinase inhibitor 2A isoform m2 (mouse) | | | | | |
| |
| |
| |
| |
| |
| |
| | | | |
|
PR:Q9R0Z3-1 | cyclin-dependent kinase inhibitor 2A isoform r1 (rat) | | | | | |
| |
| |
| | | | |
|
PR:P42771-1 | cyclin-dependent kinase inhibitor 2A isoform h1 (human) | | | | | |
| |
| | | | |
|
PR:P42771-2 | cyclin-dependent kinase inhibitor 2A isoform h2 (human) | | | | | |
| |
| | | | |
|
PR:P42771-3 | cyclin-dependent kinase inhibitor 2A isoform h3 (human) | | | | | |
| |
| | | | |
|
PR:P42771-4 | cyclin-dependent kinase inhibitor 2A isoform h5 (human) | | | | | |
| |
| |